These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3130222)

  • 21. Treatment of rhesus monkeys (Macaca mulatta) with intravaginal rings loaded with levonorgestrel.
    Wadsworth PF; Heywood R; Allen DG; Hossack DJ; Sortwell RJ; Walton RM
    Contraception; 1979 Dec; 20(6):559-67. PubMed ID: 119606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of intrauterine devices (stainless steel ring, copper-T220 and levonorgestrel) on the DNA content in isolated human endometrial cells.
    Zhu PD; Luo HZ; Cheng J; Xu RH; Liu YF; Zheng WM; Song GY; Chen JH; Zhou ZH; Wu YM
    Contraception; 1989 Nov; 40(5):591-604. PubMed ID: 2515028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysosomal enzymes in the human endometrium: a biochemical study in untreated and levonorgestrel-treated women.
    Cornillie F; Brosens I; Belsey EM; Marbaix E; Baudhuin P; Courtoy PJ
    Contraception; 1991 Apr; 43(4):387-400. PubMed ID: 1906794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
    Ling WY; Wrixon W; Zayid I; Acorn T; Popat R; Wilson E
    Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of the progesterone-releasing intrauterine device on uterine endometrium and fallopian tube epithelium.
    Sheppard BL; Bonnar J
    Arch Toxicol Suppl; 1982; 5():231-4. PubMed ID: 6954905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki PL; Luukkainen T
    Fertil Steril; 1984 Jan; 41(1):52-5. PubMed ID: 6420203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levonorgestrel-releasing intrauterine device.
    Luukkainen T
    Ann N Y Acad Sci; 1991; 626():43-9. PubMed ID: 1905510
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of intrauterine devices, the stainless steel ring, the copper T220, and releasing levonorgestrel, on the bleeding profile and the morphological structure of the human endometrium--a comparative study of three IUDs. A morphometric study of 96 cases.
    Zhu PD; Luo HZ; Xu RH; Cheng J; Wu SC; Chen JH; Wu MZ; Wang XP
    Contraception; 1989 Oct; 40(4):425-38. PubMed ID: 2510968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of intrauterine devices: biochemical changes.
    Johannisson E
    Contraception; 1987 Jul; 36(1):11-22. PubMed ID: 3311620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation.
    Pakarinen P; Luukkainen T; Laine H; Lähteenmäki P
    Hum Reprod; 1995 Sep; 10(9):2390-4. PubMed ID: 8530672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices.
    Nilsson CG; Lähteenmäki P; Robertson DN; Luukkainen T
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):380-4. PubMed ID: 7376797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
    Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
    Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial response to hormone replacement therapy as assessed by expression of insulin-like growth factor-binding protein-1 in the endometrium.
    Suhonen S; Haukkamaa M; Holmström T; Lähteenmäki P; Rutanen EM
    Fertil Steril; 1996 Apr; 65(4):776-82. PubMed ID: 8654638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD.
    Nilsson CG; Haukkamaa M; Vierola H; Luukkainen T
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):529-36. PubMed ID: 6819901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrauterine release of oestriol in castrated rhesus monkeys induces local but not peripheral oestrogenic effects: a possible approach for the treatment and prevention of Asherman's syndrome.
    Asch RH; Zuo WL; Garcia M; Ramzy I; Laufe L; Rojas FP
    Hum Reprod; 1991 Nov; 6(10):1373-8. PubMed ID: 1770129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.